文献速递免疫规划卫生政策与健康促进

2021年8月13日至11月19日美国65岁及以上成年人COVID-19疫苗加强针与额外基础剂接种情况

Booster and Additional Primary Dose COVID-19 Vaccinations Among Adults Aged ≥65 Years - United States, August 13, 2021-November 19, 2021.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2021-12-17

覆盖率性别和年龄组相近,但随基础疫苗产品和种族/族裔变化,非西班牙裔美洲印第安人或阿拉斯加原住民为30.3%,非西班牙裔多种族/其他种族为50.5%。

要点

  • 覆盖率性别和年龄组相近,但随基础疫苗产品和种族/族裔变化。
  • 非西班牙裔美洲印第安人或阿拉斯加原住民覆盖率最低为30.3%,非西班牙裔多种族/其他种族最高为50.5%。

核心结论

  • 需要采取策略性措施鼓励18岁及以上合格人群,尤其是65岁及以上和免疫功能低下者,接种加强针和/或额外基础剂以确保最大保护。

研究设计与样本

  • 分析CDC从50个州、哥伦比亚特区及8个领地和自由联系邦报告的COVID-19疫苗接种数据,以确定65岁及以上成年人加强针或额外基础剂覆盖率。

主要发现

  • 覆盖率性别和年龄组相近,但随基础系列疫苗产品和种族/族裔变化,范围从非西班牙裔美洲印第安人或阿拉斯加原住民30.3%到非西班牙裔多种族/其他种族50.5%。

临床怎么用

  • 需要采取策略性措施鼓励18岁及以上合格人群,尤其是65岁及以上和免疫功能低下者,接种加强针和/或额外基础剂以确保最大保护。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Vaccination against SARS-CoV-2 (the virus that causes COVID-19) is highly effective at preventing hospitalization due to SARS-CoV-2 infection and booster and additional primary dose COVID-19 vaccinations increase protection (1-3). During August-November 2021, a series of Emergency Use Authorizations and recommendations, including those for an additional primary dose for immunocompromised persons and a booster dose for persons aged ≥18 years, were approved because of reduced immunogenicity in immunocompromised persons, waning vaccine effectiveness over time, and the introduction of the highly transmissible B.1.617.2 (Delta) variant (4,5). Adults aged ≥65 years are at increased risk for COVID-19-associated hospitalization and death and were one of the populations first recommended a booster dose in the U.S. (5,6). Data on COVID-19 vaccinations reported to CDC from 50 states, the District of Columbia (DC), and eight territories and freely associated states were analyzed to ascertain coverage with booster or additional primary doses among adults aged ≥65 years. During August 13-November 19, 2021, 18.7 million persons aged ≥65 years received a booster or additional primary dose of COVID-19 vaccine, constituting 44.1% of 42.5 million eligible* persons in this age group who previously completed a primary vaccination series.† Coverage was similar by sex and age group, but varied by primary series vaccine product and race and ethnicity, ranging from 30.3% among non-Hispanic American Indian or Alaska Native persons to 50.5% among non-Hispanic multiple/other race persons. Strategic efforts are needed to encourage eligible persons aged ≥18 years, especially those aged ≥65 years and those who are immunocompromised, to receive a booster and/or additional primary dose to ensure maximal protection against COVID-19.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Fast HE, Zell E, Murthy BP, et al. Booster and Additional Primary Dose COVID-19 Vaccinations Among Adults Aged ≥65 Years - United States, August 13, 2021-November 19, 2021. MMWR Morb Mortal Wkly Rep. 2021. PMID: 34914672. doi:10.15585/mmwr.mm7050e2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。